NeuroTalk Support Groups - View Single Post

jana · 09-27-2010, 02:21 PM

I'm posting this entire article because you have to JOIN Medscape to view it -- NOT a big deal -- it is free -- but, I know that some of the group members had rather not. If you want to see the pictures/diagrams, you will have to join. Annie, I don't know if this is what you want/need -- but, I keep a copy in my purse......just in case!!!

http://www.medscape.com/viewarticle/439041

Quote:

Respiratory Muscle Evaluation of the Patient With Neuromuscular Disease
Vera A. DePalo, MD, F. Dennis McCool, MD

Posted: 08/29/2002; Semin Respir Crit Care Med. 2002;23(3) © 2002 Thieme Medical Publishers

Abstract and Introduction
Abstract
This review presents clinically relevant issues regarding the assessment of respiratory muscles in individuals with neuromuscular disorders, and discusses the advantages and disadvantages of methods generally available to the clinician. Vital capacity (VC) and total lung capacity (TLC) are routinely measured in pulmonary function laboratories and are typically reduced in the context of severe respiratory muscle weakness, but the sensitivity and specificity of these measures are limited. Better measures of respiratory muscle weakness are maximal static inspiratory and expiratory pressures (PI max and PE max). PI max is reduced even with mild or moderate degrees of inspiratory muscle weakness, but low values also may be related to submaximal effort. To circumvent this problem, pressures can be measured using simpler maneuvers such as a maximal sniff. Specific tests of diaphragm function such as measurements of maximal transdiaphragmatic pressure are invasive and not routinely available to the clinician. Recently, noninvasive methods that specifically assess diaphragm function, such as diaphragm ultrasound of the zone of apposition and magnetic or electrophrenic nerve stimulation, have shown promise as new techniques for clinical use.